Prognostic indices are commonly used in the context of brain metastases radiotherapy to
guide patient decision-making and clinical trial stratification. This study is to choose an …

The challenge of the management of brain metastases has not finished yet. Although new
diagnosis-specific prognostic assessment classifications and guidelines for patients with …

BACKGROUND: Stereotactic radiosurgery (SRS) is a widely accepted treatment modality for
brain metastases. The role of SRS in patients with higher numbers of metastases remains …

Background The number of metastases that can be treated safely and effectively with
Gamma Knife stereotactic radiosurgery (SRS) remains controversial despite continuing …

Purpose Stereotactic radiosurgery (SRS) is now mainstream for patients with 1-4 brain
metastases however the management of patients with 5 or more brain metastases remains …

Melanoma, the deadliest of the common skin cancers, has the highest propensity to
metastasize to the brain among solid tumors. Approximately 11% to 17% of earlystage …

Background As irradiated brain volume at 12 Gy (V12) is a predictor for radionecrosis, the
purpose of the study was to develop a model for Cyberknife (CK) plans that is able to predict …

Objective Gamma Knife (GK) stereotactic radiosurgery (SRS) is increasingly used as an
initial treatment for patients with 10 or more brain metastases. However, the clinical and …

Background Current evidence‐based guidelines support stereotactic radiosurgery (SRS) for
patients with up to four brain metastases (BMs). However, debate continues about how …

Background and Objective: A recent report indicated that metastases to other body organs
commonly develop after stereotactic body radiation treatment for cure in patients with …